Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages


This content is available also in other languages

January 15, 2007 | Customer News

Tecan's Freedom EVOlyzer® becomes SFDA-compliant in China

  Tecan has successfully registered its automated ELISA analyzer, the Freedom EVOlyzer, with the State Food and Drug Administration (SFDA) in China. New Chinese National Standards for medical electrical equipment were introduced in May 2006 and the Freedom EVOlyzer is one of the first clinical devices to become SFDA-compliant, meaning that Tecan is leading the field in its rapid implementation of the new regulations.

Seven Freedom EVOlyzer workstations were immediately ordered for customers in China following the registration. The instrument's high speed, flexibility and walkaway features are proving to be particularly important for hospitals and blood bank laboratories, and the automated ELISA platform is currently unrivaled in China.

Mark Wang, Chief Representative of Tecan China, explained: "Tecan is well equipped to serve customers in China, with a permanent office in Beijing established in 2005, as well as a strong distribution network and nine highly trained application specialists to support the customer base."

The Freedom EVOlyzer has been designed to comply with the 98/79/EC directive on in vitro diagnostic medical devices. The workstation already has plenty of satisfied customers in Europe, offering a wide range of automation options for all typical ELISA steps, including sample distribution, reagent pipetting, incubation, washing, reading and data generation. The new Freedom EVOlyzer software version 1.5, released in July 2006, includes improved error handling, more flexible scheduling and 20 per cent faster pipetting capabilities.

Not all applications discussed in this press release have been cleared for use in all countries. Contact your local sales office for specific information. 

About Tecan

Tecan (www.tecan.com) is a leading global player in the Life Sciences supply industry specializing in the development, production, and distribution of advanced automation solutions enabling pharma and academic research, diagnostics, food and veterinary research as well as forensics. Through its REMP subsidiary (www.remp.com), Tecan is the leading supplier of compound and sample storage, management and logistics solutions. Tecan clients are pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2005, Tecan achieved sales of CHF 344.9 million (USD 275.9 Mio.; EUR 222.5 Mio.). Registered shares of Tecan Group are traded on the SWX Swiss Exchange (TK: TECN / Reuters: TECZn.S / Valor: 12100191).

For further information please contact:

Tecan Switzerland AG
Seestrasse 103
CH-8708 Männedorf

T +41 44 922 81 11
F +41 44 922 81 12